Durvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trial
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Faivre-Finn, C.
Vicente, D.
Kurata, T.
Planchard, D.
Paz-Ares, L.
Vansteenkiste, J. F.
Spigel, D. R.
Garassino, M. C.
Reck, M.
Senan, S.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
